Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 12389-15-0
2. Dtxsid20924633
3. Iron(2+) Hexonate--water (1/2/2)
4. Ft-0626417
5. Ft-0626418
Molecular Weight | 482.17 g/mol |
---|---|
Molecular Formula | C12H26FeO16 |
Hydrogen Bond Donor Count | 12 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 8 |
Exact Mass | 482.057020 g/mol |
Monoisotopic Mass | 482.057020 g/mol |
Topological Polar Surface Area | 285 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 165 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 8 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
90
PharmaCompass offers a list of Ferrous Gluconate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ferrous Gluconate manufacturer or Ferrous Gluconate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ferrous Gluconate manufacturer or Ferrous Gluconate supplier.
PharmaCompass also assists you with knowing the Ferrous Gluconate API Price utilized in the formulation of products. Ferrous Gluconate API Price is not always fixed or binding as the Ferrous Gluconate Price is obtained through a variety of data sources. The Ferrous Gluconate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate, including repackagers and relabelers. The FDA regulates iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate supplier is an individual or a company that provides iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate active pharmaceutical ingredient (API) or iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate finished formulations upon request. The iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate suppliers may include iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate active pharmaceutical ingredient (API) in detail. Different forms of iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate DMFs exist exist since differing nations have different regulations, such as iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate USDMF includes data on iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate suppliers with USDMF on PharmaCompass.
A iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate CEP of the European Pharmacopoeia monograph is often referred to as a iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate Certificate of Suitability (COS). The purpose of a iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate to their clients by showing that a iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate CEP has been issued for it. The manufacturer submits a iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate CEP holder for the record. Additionally, the data presented in the iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate DMF.
A iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate suppliers with NDC on PharmaCompass.
iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate GMP manufacturer or iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate GMP API supplier for your needs.
A iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate CoA (Certificate of Analysis) is a formal document that attests to iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate's compliance with iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate specifications and serves as a tool for batch-level quality control.
iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate CoA mostly includes findings from lab analyses of a specific batch. For each iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate EP), iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (iron(2+); 2,3,4,5,6-pentahydroxyhexanoate; dihydrate USP).